June 7, 2011 — Research presented at SNM’s 58th annual meeting is taking targeted molecular imaging to a new level by ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
May 31, 2011 — UltraSPECT, a provider of nuclear medicine (NM) image reconstruction technology that reduces ...
May 26, 2011 - With the deficiencies in knowledge of tuberculosis--as well as in the practices, programs and strategies ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
May 20, 2011 – Medrad Inc., a business of Bayer HealthCare, has announced the launch of the next generation Intego PET ...
May 18, 2011 – Lantheus Medical Imaging Inc. announced data from a phase 2 clinical trial that demonstrated positron ...
May 6, 2011 – Naviscan has entered into a distribution agreement with Tecnologie Avanzate s.r.l. to market and service ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
May 4, 2011 – Researchers from the University of Cincinnati presented results from a prospective study at the American ...
A new PET/CT scanner has been introduced that helps address the increasing cost pressures faced by healthcare providers ...
SNM's Clinical Trials Network (CTN) last week validated its 100th scanner, an important milestone in CTN's two-and-a ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
April 4, 2011 – The U.S. Food and Drug Administration (FDA) has given a complete response letter to Eli Lilly and its ...
March 24, 2011 – A new study by Craig Thiessen, M.D., director of radiology for West Houston Radiology L.L.P. and North ...
An interview with Peter Herscovitch, M.D., chief of the positron emission tomography (PET) department, senior attending ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
An interview with Peter Herscovitch, M.D., chief of the positron emission tomography (PET) department, senior attending ...
March 11, 2011 – U.S. Food and Drug Administration (FDA) and Lantheus Medical Imaging Inc. today reached agreement on a ...
March 10, 2011 – The U.S. Food and Drug Administration (FDA) has granted an abbreviated new drug application (ANDA) for ...
March 4, 2011 – For the first time, quantitative—not qualitative—data analysis has demonstrated that time-of-flight (TOF ...
March 3, 2011 – A positron emission mammography (PEM) scanner has been launched at two radiology conferences in Vienna ...
March 3, 2011 – The U.S. Food and Drug Administration (FDA) has cleared a whole-body positron emission tomography (PET) ...
February 8, 2011 — The only direct National Institute of Standards and Technology (NIST) traceable dose calibrator ...
February 4, 2011 – Positron emission tomography (PET) can image metabolic changes following treatment with the protein ...
June 20, 2011 